 |
3rd Thursday Community Engagement Education Series - Final Session
|
Session 4: IRBs and Community-Engaged Research
Apr. 15, 2021, 12 - 1 p.m.
Presented by Matt Ogrodnik, MS, CIP & Mary McCabe
Human subjects research can pose challenges for community-academic partnerships, particularly given most community partner organizations do not have their own IRB of record.
- Do community partners need their own IRB?
- Should we use investigator agreements?
- Can partners access CITI training through BU?
- Are there more accessible alternatives to CITI available to community partners?
|
|
|
|
|
New Funding Opportunities |
|
|
|
|
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases (NIAID)
|
Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries
Fogarty International Center (FIC)
|
|
|
|
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
National Institute on Aging (NIA)
|
Screening and Interventions for Adverse Childhood Experiences in Primary Care Settings Demonstration Project
Department of Health and Human Services (HHS)
Health Resources and Services Administration (HRSA)
|
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS)
|
|
|
|
HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
|
Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed)
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
National Center for Advancing Translational Sciences (NCATS)
|
|
|
|
|
Initial Pre-Proposals are due to BU:
May 10, 2021
Novartis Institutes for BioMedical Research (NIBR) have invited Boston University, as one of a select group of international institutions, to participate in their NIBR Global Scholars Program 2021 (Kerberos log-in required). The program will provide BU faculty investigators with access to disease area drug-hunting and translational research expertise. Selected proposals, not funded by traditional grant support, will receive up to $1 million over three years.
|
|
|
|
2021 Call for Applications
Application Deadline: May 5, 2021
The aim for the 2021 IRL program is to generate high-quality, community-engaged research useful for dismantling structural racism and improving health and health equity. Structural racism is manifested in policies, practices, and programs in ways that segregate populations based on race and ethnicity, and create barriers to social opportunity and upward mobility. There is an urgent need to identify solutions for eliminating structural racism.
|
|
|
|
|
Mapping Severe COVID-19 in the Lungs at Single-Cell Resolution
A crucial question for COVID-19 researchers is what causes progression of the initial infection, leading to life-threatening respiratory illness. Read More
|
|
|
|
|
SARS-CoV-2 Induces Double-Stranded RNA-Mediated Innate Immune Responses in Respiratory Epithelial-Derived Cells and Cardiomyocytes
Like other RNA viruses, coronaviruses produce dsRNA early during the infection cycle as a result of genome replication and mRNA transcription Read More
|
|
|
|
|
Lessons Learned About Substance Use Disorders During the COVID-19 Pandemic
Through HEAL, we’ve launched a first-in-human test of a vaccine to protect against the harmful effects of opioids, including relapse and overdose. We’re also testing a tool that provides pharmacists with a validated opioid use disorder risk measure. Read More
|
|
|
|
|
NIH Begins Study of Allergic Reactions to Moderna, Pfizer-BioNTech COVID-19 Vaccines
A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines? Read More
|
|
|
|
|
Informatics Community Using EHR Data to Answer COVID-19 Questions: Featuring the Long-COVID Clinical Domain Team
The National COVID Cohort Collaborative (N3C) continues to grow as a robust EHR data resource, now with over 3 million persons represented and 4 billion rows of data from more than 42 sites. Read More
|
|
|
|
|
Air, Surface Environmental, and Personal Protective Equipment Contamination by SARS-CoV-2 From a Symptomatic Patient
Significant environmental contamination by patients with SARS-CoV-2 through respiratory droplets and fecal shedding suggests the environment as a potential medium of transmission. Read More
|
|
|
|
|
Upcoming Workshop & Events |
|
|
|
|
The Public-Private Partnership Hospital in Lesotho:
A Forward-Thinking Policy Ahead of Its Time?
Apr. 21, 2021, 12 - 1 p.m.
Join us for a panel discussion to explore public-private partnerships as a mechanism to finance health facilities and services in low-resource settings.
|
|
|
|
|
2021 HHS Small Business Program Conference: Diverse Perspectives SEEDing Impactful Innovations
Apr. 26 - 30, 2021
The 21st Annual HHS Small Business Program Conference helps small businesses learn more about the approximate $1.1 billion dollars of annual HHS funding that is available to forge academic partnerships and build new businesses. This annual conference is the cornerstone of HHS’s Congressionally-mandated outreach efforts for small business. More Details Here
|
|
|
|
|
The Postdoc Academy: Succeeding as a Postdoc
Apr. 26 - Jun. 7, 2021
Are you a postdoc looking for flexible professional development? Are you looking for a place to connect with and regularly interact with other postdocs? This course is built for you! More Details Here
|
Please join us for an institutional-focused PALS at Boston University!
PALS will begin on 4/28/21 at 4PM EST.
We will meet every Wednesday through the end of the course on Zoom.
|
|
|
|
|
Boston University College of Engineering
Presents
The Charles DeLisi Distinguished Lecture Award Event
May 6, 2021, 4 - 5:30 p.m.
|
WEBINAR Lecture Award Speaker:
Yannis Paschalidis, Ph.D., Professor (ECE, BME, SE)
“Data Science & Optimization Adventures in Computational Biology & Medicine”
The Charles DeLisi Distinguished Lecture Award celebrates the outstanding research accomplishments of a senior faculty member in the College. Register Here
|
|
|
|
|
Call for Applications: 2021 Design Labs in Clinical Effectiveness Trial
Application Closes: May 7, 2021
|
Are you a clinical investigator looking to design and run an innovative clinical trial that will inform real-world practice? Are you pursuing an innovative clinical trial design and would like expert and stakeholder feedback to advance your design and trial? If so, consider applying to take part in our 2021 Innovations in Clinical Effectiveness Trial Design Lab! More Details Here
|
|
|
|
|
Research in human genomics will have moved beyond population descriptors based on historic social constructs such as race.
May 25, 2021, 3 - 4:30 p.m.
|
NHGRI will host the third seminar in a series focused on the “Bold Predictions for Human Genomics by 2030” that are described in NHGRI’s “Strategic Vision for Improving Human Health at the Forefront of Genomics.” For each session, two speakers will use a specific bold prediction as an aspirational theme to discuss their own research and speculate about the next decade of genomic advancements. A moderated question and answer session will follow the speakers.
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
|
|
|
|
|
|
